Injection, gadoterate meglumine, 0.1 ml
HCPCS code
Name of the Procedure:
Common name(s): MRI Contrast Injection
Technical/medical term: Injection, gadoterate meglumine, 0.1 ml (HCPCS Code: A9575)
Summary:
The injection of gadoterate meglumine, commonly referred to as an MRI contrast injection, involves administering a special dye to enhance the clarity of magnetic resonance imaging (MRI) scans. This contrast agent helps highlight blood vessels, tissues, and organs more clearly, allowing for more accurate diagnosis.
Purpose:
The procedure is primarily used to:
- Enhance the visibility of blood vessels, tissues, and organs.
- Diagnose and monitor various medical conditions such as tumors, vascular diseases, and brain disorders.
- Improve the accuracy and efficacy of MRI scans.
Indications:
This procedure is often indicated for:
- Patients exhibiting symptoms of tumors, brain abnormalities, and vascular diseases.
- Individuals requiring high-detail imaging for surgical planning or monitoring of known medical conditions.
- Patients with inconclusive or unclear MRI results without contrast.
Preparation:
- Patients are generally advised to fast for a few hours before the procedure.
- Disclosure of any allergies, particularly to contrast materials, is essential.
- Certain medications may need to be adjusted or paused prior to the injection.
- Hydration is encouraged unless otherwise specified by the healthcare provider.
Procedure Description:
- Informed consent is obtained.
- The patient is positioned on the MRI scanner table.
- An IV line is inserted into a vein, usually in the arm.
- Gadoterate meglumine is slowly injected through the IV line.
- During the MRI scan, contrast-enhanced images are taken.
- The IV line is removed post-scan.
Tools and Equipment:
- MRI machine
- IV line and injection syringe containing gadoterate meglumine
Anesthesia/Sedation:
- Usually not required, but mild sedation may be offered for anxious patients.
Duration:
The actual injection takes a few minutes, but the entire MRI procedure may last between 30-60 minutes.
Setting:
The procedure is performed in a radiology department, typically within a hospital or an outpatient imaging center.
Personnel:
The team usually includes:
- Radiologist
- Radiologic technologist
- Nurse
Risks and Complications:
Common risks:
- Mild allergic reactions (itching, rashes)
- Discomfort or pain at the injection site
Rare risks:
- Severe allergic reactions (anaphylaxis)
- Nephrogenic systemic fibrosis (extremely rare, primarily in patients with chronic kidney disease)
Benefits:
- Improved diagnostic accuracy due to clearer imaging.
- Enhanced ability to detect and monitor abnormalities.
- More targeted treatment planning.
Recovery:
- Patients can usually resume normal activities immediately after the procedure.
- It is advised to drink plenty of fluids to help flush the contrast material from the body.
- Any discomfort at the injection site typically resolves within a few hours.
Alternatives:
- MRI without contrast, though it may not provide as clear or detailed images.
- Other imaging modalities such as CT scans or ultrasounds, depending on clinical indication.
- Each alternative has its pros and cons which should be discussed with a healthcare provider.
Patient Experience:
- Mild discomfort may be felt at the injection site.
- Some patients may feel a cool sensation as the contrast material is injected.
- The MRI scan itself involves lying still in a narrow tube, which may cause claustrophobia in some patients, managed with relaxation techniques or mild sedation.